Natafort
NDC Package 0178-0716-90
Package Information
Natafort is ® is a multivitamin/mineral prescription drug indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers. Marketed by Mission Pharmacal Company, this product is identified by NDC 0178-0716.
Identification & Billing
- RxCUI: 1304497 - alpha-tocopherol acetate 11 UNT / ascorbic acid 120 MG / cholecalciferol 400 UNT / folic acid 1 MG / iron carbonyl 60 MG / niacinamide 20 MG / pyridoxine hydrochloride 10 MG / riboflavin 3 MG / thiamine mononitrate 2 MG / vitamin B12 0.012 MG Oral Tablet
- RxCUI: 1304497 - alpha-tocopherol acetate 11 UNT / vitamin C 120 MG / cholecalciferol 400 UNT / folate 1 MG / iron carbonyl 60 MG / niacinamide 20 MG / vitamin B6 hydrochloride 10 MG / riboflavin 3 MG / vitamin B1 mononitrate 2 MG / vitamin B12 0.012 MG Oral Tablet
- RxCUI: 1304497 - alpha-tocopherol acetate 11 UNT / vitamin C 120 MG / cholecalciferol 400 UNT / folate 1 MG / iron carbonyl 60 MG / niacinamide 20 MG / vitamin B6 hydrochloride 10 MG / riboflavin 3 MG / vit-B1 mononitrate 2 MG / vitamin B12 0.012 MG Oral Tablet
- RxCUI: 1304497 - alpha-tocopherol acetate 11 UNT / vitamin C 120 MG / cholecalciferol 400 UNT / folate 1 MG / iron carbonyl 60 MG / niacinamide 20 MG / vit-B6 hydrochloride 10 MG / riboflavin 3 MG / vitamin B1 mononitrate 2 MG / vitamin B12 0.012 MG Oral Tablet
- RxCUI: 1304497 - alpha-tocopherol acetate 11 UNT / vitamin C 120 MG / cholecalciferol 400 UNT / folate 1 MG / iron carbonyl 60 MG / niacinamide 20 MG / vit-B6 hydrochloride 10 MG / riboflavin 3 MG / vit-B1 mononitrate 2 MG / vitamin B12 0.012 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0178 - Mission Pharmacal Company
- 0178-0716 - Natafort
- 0178-0716-90 - 90 TABLET in 1 BOTTLE
- 0178-0716 - Natafort
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0178-0716-90 identifies a specific commercial package of 90 tablet in 1 bottle of Natafort, labeled by Mission Pharmacal Company. This product is billed for "EA" each discreet unit and contains an estimated amount of 90 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Mission Pharmacal Company on August 25, 2011. The current certification is valid through December 31, 2017.
How is this Mission Pharmacal Company product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00178071690. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 90 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.